| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |